Avsar.

Healthcare · Pharmaceuticals

RPG Life Sciences Ltd (RPGLIFE)

₹2,937.00

Mkt cap
₹3,765 Cr
P/E ratio
33.50
P/B
8.02
Div yield
1.05%
ROE
19.80%
ROCE
26.20%
EPS (TTM)
₹87.67
Book value
₹366
52W range
1,744–3,017
Sector
Healthcare

Incorporated in 2007, RPG Life Sciences Ltd manufactures and markets Formulations (Finished Dosage Forms) and Active Pharma Ingredients [1]

NSE RPGLIFEBSE 532983www.rpglifesciences.com
Health check
Constructive
ValuationFair
ProfitabilityStrong
GrowthModerate
TechnicalsBullish
52-week range
−2.65% from high
₹2,937
₹1,744+68.41% from low₹3,017
Current
₹2,937.00
Prev close
₹2,900.00
Day
+1.28%
Price performance
1D
+1.28%
1W
−2.65%
1M
+29.02%
3M
+44.46%
6M
+31.82%
1Y
+15.23%
YTD
+27.01%

Financials

F
Revenue, profit & margin
P/E ratio
33.5×
RPGLIFE is 1% above the sector median of 33.3×
RPGLIFE33.5×
Sector median33.3×
 Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Trend
Sales118148154154127165172173143169182180177
Expenses103116116116106126126124118133143140144
Operating Profit16323738213946492535394033
OPM %13%22%24%25%16%24%27%28%18%21%21%22%19%
Other Income222222-253115516-513
Interest0000000000000
Depreciation4444455555556
Profit before tax143035361836154713535492940
Tax %25%26%26%26%25%26%72%26%13%26%25%24%26%
Net Profit10222626132743511726372230
EPS in Rs6.2613.3615.6416.008.0116.182.5421.1270.9515.9022.2813.3818.08
Raw PDF

Earnings

EResults dates & reactions
Next results
28 Jul '26scheduled

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

No reaction history yet.
No quarterly filings ingested yet.

Corporate actions

CLast 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

Sas of Mar 2026
72.95%Promoter
Promoters72.95%
FIIs0.87%0.13
DIIs7.45%0.41
Public18.72%0.29
Ownership trend

Peers

P8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,862.8035.824,46,9480.86%2,710+13.58%14,612+12.76%20.53%
Divi's Lab.₹6,713.5067.941,78,2220.45%751+13.44%2,831+9.52%21.96%
Torrent Pharma.₹4,516.2069.741,52,8490.84%364−20.58%4,197+41.84%15.19%
Cipla₹1,440.1030.561,16,3380.90%543−54.61%6,541−2.80%15.49%
Dr Reddy's Labs₹1,350.5026.861,12,7230.59%221−86.14%7,546−11.51%13.64%
Zydus Lifesci.₹1,101.4020.431,10,8270.09%1,341+21.92%7,587+16.22%21.15%
Lupin₹2,343.5018.591,07,1520.51%1,469+101.49%7,475+31.89%30.32%
RPG LifeScience.₹2,276.4033.543,7651.05%30+33.70%177+23.62%26.16%
Median: 157 Co.₹408.3033.251,7980.09%12+22.34%177+16.22%15.14%

Filings

D
Annual reports15
Financial Year 2025bseFinancial Year 2024bseFinancial Year 2023bseFinancial Year 2022bseFinancial Year 2021bseFinancial Year 2020bseFinancial Year 2019bseFinancial Year 2018bseFinancial Year 2017bseFinancial Year 2016bseFinancial Year 2015bseFinancial Year 2014bseFinancial Year 2013bseFinancial Year 2012bseFinancial Year 2011nse
Concall transcripts46
PPTRECPPTPPTTranscriptPPTRECPPTPPTTranscriptPPTRECPPTTranscriptRECPPTPPTTranscriptPPTPPTTranscriptPPTPPTPPT
Credit ratings6
Rating update 4 Apr 2025icraRating update 6 Mar 2024icraRating update 15 Dec 2022icraRating update 17 Dec 2020icraRating update 29 Nov 2019icraRating update 20 Aug 2018icra
Announcements5
Closure of Trading Window 25 Jun - Trading window closes from July 1, 2026 until 48 hours after Q1 results.Announcement under Regulation 30 (LODR)-Newspaper Publication 23 JunRecord Date For Determining Members Eligible To Receive Dividend For The Financial Year 2025-26. 22 JunClarification For Volume Movement Letter 12 Jun - Company clarified increased trading volume has no unpublished price-sensitive information.Clarification sought from RPG Life Sciences Ltd 12 Jun - Exchange has sought clarification from RPG Life Sciences Ltd on June 12, 2026, with reference to Movement in Volume.